Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition.
![Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition](https://image.cnbcfm.com/api/v1/image/107393001-17114709252023-03-29t000000z_1653336606_rc2w30aoohoj_rtrmadp_0_usa-health.jpeg?v=1711470985&w=1920&h=1080)
Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
Total Vote: 2
Ossufo Momade
Carlitos Nov 19, 2022 0
Carlitos Sep 16, 2022 0
Carlitos Aug 18, 2022 0
TORRE Admin Jan 15, 2024 0
TORRE Jun 27, 2024 0
TORRE Jun 4, 2024 0
TORRE Jun 4, 2024 0
TORRE Jun 4, 2024 0